Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MP0274 |
Synonyms | |
Therapy Description |
MP0274, is a bivalent designed ankyrin repeat protein (DARPin) that specifically binds Erbb2 (Her2), which potentially inhibits Erbb2 (Her2) and Erbb3 (Her3) signaling, leads to apoptosis and tumor growth inhibition (Cancer Res 2013;73(24 Suppl): Abstract nr P4-12-30). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MP0274 | MP 0274|MP-0274 | HER2 (ERBB2) Antibody 72 | MP0274, is a bivalent designed ankyrin repeat protein (DARPin) that specifically binds Erbb2 (Her2), which potentially inhibits Erbb2 (Her2) and Erbb3 (Her3) signaling, leads to apoptosis and tumor growth inhibition (Cancer Res 2013;73(24 Suppl): Abstract nr P4-12-30). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|